Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Non-fermentative Gram-negative bacteria.

D A Enoch1, C I Birkett, H A Ludlam

  • 1Clinical Microbiology and Public Health Laboratory, Addenbrooke's Hospital, Hills Road, Cambridge CB2 2QW, UK. david.enoch@addenbrookes.nhs.uk

International Journal of Antimicrobial Agents
|August 3, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A practical approach to screening for carbapenemase-producing Enterobacterales- views of a group of multidisciplinary experts from English hospitals.

BMC infectious diseases·2024
Same author

The role of hospital antimicrobial and infectious diseases pharmacists in the UK: a theoretically underpinned exploration.

JAC-antimicrobial resistance·2023
Same author

Temocillin use as a carbapenem-sparing option in a UK teaching hospital for treating serious Gram-negative bacterial infections.

JAC-antimicrobial resistance·2022
Same author

Corrigendum to Joint Healthcare Infection Society (HIS) and Infection Prevention Society (IPS) guidelines for the prevention and control of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. J Hosp Infect 118 (2021) S1 - S39.

The Journal of hospital infection·2022
Same author

Joint Healthcare Infection Society (HIS) and Infection Prevention Society (IPS) guidelines for the prevention and control of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities.

The Journal of hospital infection·2021
Same author

The impact of an antifungal stewardship team on voriconazole therapeutic drug monitoring in a UK tertiary hospital.

The Journal of infection·2021

Non-fermenting Gram-negative bacteria are a growing threat to immunocompromised patients due to widespread drug resistance. Further research is needed to determine if combination therapy can extend the effectiveness of new antimicrobial drugs.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Non-fermenting Gram-negative bacteria are increasingly recognized as opportunistic pathogens.
  • These bacteria are prevalent in the environment and exhibit significant antimicrobial resistance.
  • Infections caused by these pathogens present challenges in treatment and control.

Purpose of the Study:

  • To address the growing problem of drug-resistant non-fermenting Gram-negative bacterial infections.
  • To investigate potential strategies for improving the treatment of infections caused by these opportunistic pathogens.

Main Methods:

  • This study focuses on the clinical and microbiological aspects of non-fermenting Gram-negative bacterial infections.
  • The research emphasizes the need for urgent assessment of therapeutic approaches.

Related Experiment Videos

Main Results:

  • Non-fermenting Gram-negative bacteria pose a significant threat due to their drug resistance.
  • The rapid emergence of resistance to new antimicrobial agents is a major concern.

Conclusions:

  • Combination therapy may offer a way to improve the long-term clinical utility of new antimicrobial drugs.
  • Further studies are essential to evaluate combination therapy for non-fermenter infections.